Post-transcriptional markers associated with clinical complications in Type 1 and Type 2 diabetes mellitus (2019)
- Authors:
- Massaro, Juliana Doblas
- Polli, Claudia Danella
- Silva, Matheus Costa e
- Alves, Cinthia Caroline
- Passos Junior, Geraldo Aleixo da Silva
- Sakamoto-Hojo, Elza Tiemi
- Miranda, Wallace Rodrigues de Holanda
- Cezar, Nathalia Joanne Bispo
- Rassi, Diane Meyre
- Crispim, Felipe
- Dib, Sergio Atala
- Foss-Freitas, Maria Cristina
- Pinheiro, Daniel Guariz
- Donadi, Eduardo Antônio
- Massaro, Juliana Doblas
- USP affiliated authors: PASSOS JUNIOR, GERALDO ALEIXO DA SILVA - FORP ; HOJO, ELZA TIEMI SAKAMOTO - FFCLRP ; FREITAS, MARIA CRISTINA FOSS DE - FMRP ; DONADI, EDUARDO ANTONIO - FMRP ; MASSARO, JULIANA DOBLAS - FMRP ; POLLI, CLÁUDIA DANELLA - FMRP ; SILVA, MATHEUS COSTA E - FMRP ; ALVES, CINTHIA CAROLINE - FMRP ; CEZAR, NATHÁLIA JOANNE BISPO - FMRP ; RASSI, DIANE MEYRE - FMRP ; MIRANDA, WALLACE RODRIGUES DE HOLANDA - FMRP
- Unidades: FORP; FFCLRP; FMRP
- DOI: 10.1016/j.mce.2019.03.008
- Subjects: BIOMARCADORES; DIABETES MELLITUS; MICRORNAS
- Keywords: Type 1 diabetes; Type 2 diabetes; Diabetes microvascular complications; miRNome analysis; Biomarkers
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Molecular and Cellular Endocrinology
- ISSN: 0303-7207
- Volume/Número/Paginação/Ano: v. 490, p. 1-14, 2019
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MASSARO, Juliana Doblas et al. Post-transcriptional markers associated with clinical complications in Type 1 and Type 2 diabetes mellitus. Molecular and Cellular Endocrinology, v. 490, p. 1-14, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.mce.2019.03.008. Acesso em: 29 dez. 2025. -
APA
Massaro, J. D., Polli, C. D., Silva, M. C. e, Alves, C. C., Passos Junior, G. A. da S., Sakamoto-Hojo, E. T., et al. (2019). Post-transcriptional markers associated with clinical complications in Type 1 and Type 2 diabetes mellitus. Molecular and Cellular Endocrinology, 490, 1-14. doi:10.1016/j.mce.2019.03.008 -
NLM
Massaro JD, Polli CD, Silva MC e, Alves CC, Passos Junior GA da S, Sakamoto-Hojo ET, Miranda WR de H, Cezar NJB, Rassi DM, Crispim F, Dib SA, Foss-Freitas MC, Pinheiro DG, Donadi EA. Post-transcriptional markers associated with clinical complications in Type 1 and Type 2 diabetes mellitus [Internet]. Molecular and Cellular Endocrinology. 2019 ; 490 1-14.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.mce.2019.03.008 -
Vancouver
Massaro JD, Polli CD, Silva MC e, Alves CC, Passos Junior GA da S, Sakamoto-Hojo ET, Miranda WR de H, Cezar NJB, Rassi DM, Crispim F, Dib SA, Foss-Freitas MC, Pinheiro DG, Donadi EA. Post-transcriptional markers associated with clinical complications in Type 1 and Type 2 diabetes mellitus [Internet]. Molecular and Cellular Endocrinology. 2019 ; 490 1-14.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.mce.2019.03.008 - Transcript expression profiles and microRNA regulation indicate an upregulation of processes linked to oxidative stress, DNA repair, cell death, and inflammation in type 1 diabetes mellitus patients
- Changes in the gene expression profiling of the thymus in response to fibrosarcoma growth
- Gene expression using microarrays technology in systemic lupus erythematosus patients
- Promiscuous gene expression in the thymus: the root of central tolerance
- Alterações na expressão gênica correlacionada à indução de morte celular pelo antitumoral cisplatina em linhagem de glioma (U343 MG-a)
- Onset of promiscuous gene expression in murine fetal thymus organ culture
- Cisplatin-induced DNA lesions leading to HR and NHEJ repair pathways in normal, ATM and XPA deficient cell lines
- Hybridization signatures during thymus ontogeny reveals modulation of genes coding for T-cell signalling proteins
- In silico analysis of transcription factors associated to differentially expressed genes in irradiated glioblastoma cell lines
- Human and mouse transcriptome profiling reveals participation of genes located at type 1 Diabetes susceptibility regions
Informações sobre o DOI: 10.1016/j.mce.2019.03.008 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
